Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

D-BOX Technologies, Inc. to Launch Motion Seating in Multiple Auditoriums at Marcus Theatres Locations in Oakdale, Minn. and Orland Park, Ill.

globenewswire.com
MCS

Kaplan Fox Encourages Investors of The Ensign Group, Inc. (ENSG) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation Ready to Announce with Confidence?

newsfilecorp.com
ENSG

AVAV EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds AeroVironment (AVAV) Investors of Securities Class Action Lawsuit Deadline on July 27, 2026 Ready to Announce with Confidence?

newsfilecorp.com
AVAV

Corteva Declares Quarterly Dividend

prnewswire.com
CTVA

ERAS Investor Alert: HBSS Investigating Pending Claims Against Erasca (ERAS) in Securities Class Action Arising from Patent Litigation and Patient Safety Risks

prnewswire.com
ERAS

HAGENS BERMAN, SOBOL SHAPIRO LLP ALERT: GRAIL, Inc. (NASDAQ: GRAL) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 4, 2026 Lead Plaintiff Deadline

prnewswire.com
GRAL

INVESTOR ALERT: Photronics, Inc. (PLAB) Investors with Substantial Losses Have Opportunity to Lead Photronics Class Action Lawsuit

prnewswire.com
PLAB

BRCB INVESTOR DEADLINE: Black Rock Coffee Bar, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - HBSS

prnewswire.com
BRCB

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

globenewswire.com
NAMS

Exyn Defense Expands into Multi-Billion-Dollar Defense Sustainment Market, Bringing Field-Proven AI Autonomy to U.S. Air Force Aircraft Readiness

globenewswire.com
EXYN
View all news →